Results 31 to 40 of about 3,977 (203)

Decreased serum arylesterase activity in autism spectrum disorders.

, 2010
The PON1 gene, previously found associated with autism spectrum disorders (ASDs), encodes a serum protein responsible for the detoxification of organophosphates (OPs) and able to exert several enzymatic activities.
Smith, CJ, Brautigam, S, Craig, David W., Redman, M, Persico, Antonio M., Melmed, R, Marsillach, J, Persico, A.M., Lintas, C, Sacco, R, Craig, DW, Gaita, L, Pawlowski, Tracy L., Brautigam, Sarah, Huentelman, MJ, Persico, AM., Manzi, B, CURATOLO, PAOLO, Ober-Reynolds, S, Smith, Christopher J., Redman, Margot, Altieri, Laura, Curatolo, P, Sacco, Roberto, Pawlowski, TL, Lombardi, F, Camps, J, Manzi, Barbara, Lintas, Carla, Ober-Reynolds, Sharman, Ober Reynolds, S, Lombardi, Federica, Gaita, Laura, Altieri, L, Melmed, Raun, Marsillach, Judith, Huentelman, Matthew J., Camps, Jordi, Matthew J. Huentelman, Jordi Camps, Antonio M. Persico, David W. Craig, Carla Lintas, Laura Gaita, Raun Melmed, Paolo Curatolo, Barbara Manzi, Christopher J. Smith, Tracy L. Pawlowski, Roberto Sacco, Sharman Ober-Reynolds, Laura Altieri, Federica Lombardi, Margot Redman, Sarah Brautigam, Judith Marsillach   +55 more
core   +1 more source

Study of Oxidative Stress Marker Serum Paraoxonase in Metabolic Syndrome

Endocrinology Research and Practice, 2016
Purpose: The metabolic syndrome (MetS) is a constellation of interrelated risk factors of metabolic origin that appear to promote development of cardiovascular disease.
Mohit Rojekar, Mukund Mogarekar, Arati Adhe-Rojekar   +2 more
doaj   +1 more source

Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis

Molecules, 2021
Oxidative stress is involved in the pathophysiology of nonalcoholic fatty liver disease (NAFLD). However, reliable biomarkers of NAFLD in relation to oxidative stress are not available.
Kazuhiko Kotani, Jun Watanabe, Kouichi Miura, Alejandro Gugliucci   +3 more
doaj   +1 more source

Arylesterase activity in trace element contaminated soils

, 2011
Arylesterase activity was measured along with microbial biomass C (BC) and respiration, and H2O-soluble and NH4NO3-exchangeable trace elements (TE), in contaminated soils (TECS) from three long-term field trials.
Mench M., Renella, G., Landi, L., Nannipieri, P., Zornoza R., R. Zornoza, L. Landi, Zornoza, R., Nannipieri P., Renella G., P. Nannipieri, Landi L., G. Renella, Mench, Michel, M. Mench, Nannipieri, Paolo, Landi, Loretta, Renella, Giancarlo   +17 more
core   +1 more source

Serum Paraoxonase (Arylesterase) Activity in Chronic Renal Failure

, 2011
Background: Mortality rates are higher among patients with chronic renal failure with a good proportion of this excess burden being attributable to cardiovascular disease.
Balasubramaniam Gayathri, Duraisamy Vijaya, Anand Usha   +2 more
core   +1 more source

The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender [PDF]

The Ukrainian Biochemical Journal, 2016
Elevated serum ferritin (SFer) levels have been associated with chronic diseases such as coronary heart disease and diabetes mellitus type 2. The aim of this study was to examine the relationship between SFer levels and serum lipid parameters, and how ...
Hamit Yasar Ellidag, Esin Eren, Mehmet Akdag, Ozlem Giray, Kemal Kiraz, Necat Yilmaz   +5 more
doaj   +1 more source

Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis

Antioxidants, 2023
Paraoxonase-1 (PON1) is an antioxidant enzyme associated with high-density lipoproteins (HDL). Reduced serum PON1 activity is found in diseases marked by oxidative stress and inflammation, but its role in obesity remains unclear.
Helena Castañé, Andrea Jiménez-Franco, Cristian Martínez-Navidad, Cristina Placed-Gallego, Vicente Cambra-Cortés, Adelina-Miruna Perta, Marta París, Daniel del Castillo, Meritxell Arenas, Jordi Camps, Jorge Joven   +10 more
doaj   +1 more source

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis

, 2022
Aim: To review and compare the PON-1 arylesterase activity between coronary artery disease (CAD) and non-CAD patients. Methods: Data were obtained by searching MEDLINE and Scopus for all investigations published between January 1, 2000 and March 1, 2021 ...
Zuin M., D'Amuri A., Bosi C., Passaro A., Trentini A., Roncon L., Zuliani G., Marsillach J., Mackness M., Cervellati C., Loris Roncon, Giovanni Zuliani, Cristina Bosi, Angelina Passaro, Andrea D’Amuri, Carlo Cervellati, Alessandro Trentini, Marco Zuin, Judit Marsillach, Mike Mackness   +19 more
core   +1 more source

Metal‐Dependent Effects and Crowding Robustness of Pseudomonas fluorescens Esterase I

ChemBioChem, Volume 27, Issue 11, 15 June 2026.
Pseudomonas fluorescens esterase I retains catalytic activity in metal‐rich and crowded environments, despite metal‐specific inhibitory effects. These findings highlight its robustness for biocatalytic applications in complex environments. Industrial biocatalysts are strongly influenced by their physicochemical environment, yet systematic studies on ...
Emmanouil Ntermanakis, Nikoleta Syngelaki, Alexandros Lyratzakis, Renia Fotiadou, Spyridoula Charova, Ioannis V. Pavlidis, Angeliki Giannouli   +6 more
wiley   +1 more source

Unlocking Lactonase Enzymes as Biocatalysts for the Deracemisation of Chiral γ‐Thiolactones

Angewandte Chemie, Volume 137, Issue 29, July 14, 2025.
The application of lactonase enzymes as biocatalysts still remains underexplored. This study discloses the biocatalytic activity of two lactonases in the deracemisation of chiral C3‐substituted‐γ‐thiolactones. The biocatalyst GcL catalyses the enzymatic kinetic resolution (EKR) of C3‐amide‐thiolactones, while the rationally engineered biocatalyst N9 ...
Jingyue Wu, Michele Crotti, Ivan Bassanini, Mahdi Hassankalhori, Erica Elisa Ferrandi, Ferran Sancho, Daniela Monti, Daniele Castagnolo   +7 more
wiley   +2 more sources